Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks
UPDATED Jan 14, 2026
Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VLS | AU$2.82 | 7.6% | 41.7% | AU$154.0m | n/a | 16.5 | n/a | 3.5% | ||
VIT | AU$0.06 | 0% | -27.7% | AU$39.8m | n/a | 12.0 | n/a | 3.3% | ||
CSL | AU$175.28 | 0.5% | -36.4% | AU$84.5b | AU$234.14 | 18.9 | 10.1% | 2.5% | ||
CUV | AU$12.75 | 0.9% | 8.1% | AU$640.1m | AU$24.53 | 17.7 | 23.9% | 0.4% | ||
CTE | AU$1.01 | 1.0% | 40.3% | AU$49.3m | n/a | 26.2 | n/a | 0% | ||
ACR | AU$0.014 | -6.7% | -56.3% | AU$5.7m | n/a | 4.8 | n/a | 0% | ||
MVP | AU$0.55 | 0% | 32.5% | AU$62.0m | AU$2.29 | 659.2 | 67.1% | 0% |
Page 1 of 1